FRANKLIN LAKES, N.J.— Becton Dickinson (BD) has rolled out its new 6mm x 32G Ultra-Fine micro pen needle.

With the launch, BD is providing health care providers with an additional needle length option for people with diabetes who inject insulin.

The introduction of the new pen needle rounds out the BD Ultra-Fine pen needle portfolio, which now includes 4mm x 32G, 5mm x 31G, 6mm x 32G, 8mm x 31G and 12.7mm x 29G. BD Ultra-Fine micro 6mm pen needles are covered at the preferred co-pay by most insurance plans, including Medicare Part D, and are compatible with leading pen injection devices.

With shorter needles, including BD Ultra-Fine micro pen needles, people with diabetes are less likely to accidentally inject their insulin dose into a muscle, BD said. People with diabetes typically inject insulin one or more times per day into the subcutaneous fat of their abdomen, thigh, upper arm or buttocks.

The BD Ultra-Fine pen needles are designed for a comfortable injection experience, the company said. They include electro-polished, surgical-grade needles for smoothness and a proprietary micro-bonded needle lubrication for less friction. In addition, all BD Ultra-Fine pen needles designed to deliver a full, accurate dose.

“We added the BD Ultra-Fine micro pen needles to ensure BD has a comprehensive portfolio that provide options to patients and reinforces BD’s commitment to providing the best solutions possible for people with specific preferences while managing their diabetes and striving for the best clinical outcomes,” according to Nabil Shabshab, worldwide president of diabetes care and digital health for BD. “This new needle will help ensure that people with diabetes who prefer a 6mm pen needle will be able to experience the quality and performance of BD Ultra-Fine pen needles.”